Cyclic adenosine monophosphate (cAMP) increases natriuretic peptide receptor C (NPR-C) expression in human aortic smooth muscle cells

Molecular and Cellular Endocrinology

Volumn 219, Issue 1-2, 2004, Pages 161-169

  Puggina, E ^a,b   Sellitti, D ^a  

^a Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center   (United States)

^b METHODIST UNIVERSITY OF PIRACICABA   (Brazil)

Author keywords

Cyclic adenosine monophosphate (cAMP); Natriuretic peptide receptors; Vascular smooth muscle

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BUCLADESINE; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; CYCLIC GMP; FORSKOLIN; IODINE 125; ISOBUTYLMETHYLXANTHINE; ISOPRENALINE; KT 5720; NATRIURETIC FACTOR; NATRIURETIC PEPTIDE RECEPTOR A; NATRIURETIC PEPTIDE RECEPTOR B; NATRIURETIC PEPTIDE RECEPTOR C; PHOSPHODIESTERASE INHIBITOR; PROTEIN; UNCLASSIFIED DRUG;

AORTA; ARTICLE; BINDING AFFINITY; CELL CULTURE; CONTROLLED STUDY; HUMAN; HUMAN CELL; INCUBATION TIME; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; STIMULATION; UPREGULATION;

1-METHYL-3-ISOBUTYLXANTHINE; AORTA; ATRIAL NATRIURETIC FACTOR; BUCLADESINE; CARBAZOLES; CELL CULTURE TECHNIQUES; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; CYCLIC GMP; FORSKOLIN; GUANYLATE CYCLASE; HUMANS; INDOLES; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PROTEIN BINDING; PYRROLES; RECEPTORS, ATRIAL NATRIURETIC FACTOR; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 2442445000     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2003.12.015     Document Type: Article

References (19)

1. Anand-Srivastava M.B., Trachte G.J. Atrial natriuretic factor receptors and signal transduction mechanisms. Pharmacol. Rev. 45:1993;455-497
2. Beavo J.A. Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms. Physiol. Rev. 75:1995;725-748
3. Boumati M., Li Y., Anand-Srivastava M.B. Modulation of ANP-C receptor signaling by arginine-vasopressin in A-10 vascular smooth muscle cells: role of protein kinase. Arch. Biochem. Biophys. 415:2003;193-202
4. Casco V.H., Veinot J.P., Kuroski de Bold M.L., Masters R.G., Stevenson M.M., de Bold A.J. Natriuretic peptide system gene expression in human coronary arteries. J. Histochem. Cytochem. 50:2002;799-809
5. Chauhan S.D., Nilsson H., Ahluwalia A., Hobbs A.J. Release of C-type natriuretic peptide accounts for the biological activity of endothelium-derived hyperpolarizing factor. Proc. Natl. Acad. Sci. 100:2003;1426-1431
6. Corti R., Burnett J.C., Rouleau J.L., Ruschitzka F., Luscher T.F. Vasopeptidase inhibitors. A new therapeutic concept in cardiovascular disease? Circulation. 104:2001;1856-1862
7. Drewett J.G., Fendly B.M., Garbers D.L., Lowe D.G. Natriuretic peptreceptor-B (guanylyl cyclase-B) mediates C-type natriuretic peptide relaxation of precontracted rat aorta. J. Biol. Chem. 270:1995;4668-4674
8. Hutchinson H.G., Trindade P.T., Cunanan D.B., Wu C.-F., Pratt R.E. Mechanisms of natriuretic-peptide-induced growth inhibition of vascular smooth muscle cells. Cardiovasc. Res. 35:1997;158-167
9. Kishimoto I., Yoshimasa T., Suga S., Ogawa Y., Komatsu Y., Nakagawa O., Itoh H., Nakao K. Natriuretic peptide clearance receptor is transcriptionally down-regulated by beta 2-adrenergic stimulation in vascular smooth muscle cells. J. Biol. Chem. 269:1994;28300-28308
10. Kohno M., Yokokawa K., Yasunari K., Kano H., Minami M., Ueda M., Yoshikawa J. Effect of natriuretic peptide family on the oxidized LDL-induced migration of human coronary artery smooth muscle cells. Circ. Res. 81:1997;585-590
11. Murthy K.S., Makhlouf G.M. Identification of the G protein-activating domain of the natriuretic peptide clearance receptor (NPR-C). J. Biol. Chem. 274:1999;17587-17592
12. Sellitti D.F., Doi S.Q. Regulation of natriuretic peptide receptors by thyrotropin in FRTL-5 rat thyroid cells: evidence for nonguanylate cyclase atrial natriuretic factor-binding sites in cells lacking the natriuretic peptide receptor C. Endocrinology. 140:1999;1365-1374
13. Sellitti D.F., Puggina E.F., Lagranha C., Doi S.Q. Cyclic adensosine monophosphate (cAMP) inhibits C-type natriuretic peptide receptor (NPR-B) activity and increases CNP in FRTL-5 rat thyroid cells. J. Endocrinol. 180:2004;23-34
14. Suga S., Nakao K., Itoh H., Komatsu Y., Ogawa Y., Hama N., Imura H. Endothelial production of C-type natriuretic peptide and its marked augmentation by transforming growth factor-beta. Possible existence of "vascular natriuretic peptide system" J. Clin. Invest. 90:1992;1145-1149
15. Suga, S., Nakao, K., Kishimoto, I., Hosoda, K., Mukoyama, M., Arai, H., Shirakama, G., Ogawa, Y., Komatsu, Y., Nakagawa, et al., 1992b. Phenotype-related alteration in expression of natriuretic peptide receptors in aortic smooth muscle cells. Circ. Res. 71, 34-39.
16. Werstiuk E.S., Lee R. Vascular β-adrenoreceptor function in hypertension and in ageing. Can. J. Physiol. Pharmacol. 78:2000;433-452
17. Yanaka N., Kotera J., Taguchi I., Sugiura M., Kawashima K., Omori K. Structure of the 5′-flanking regulatory region of the mouse gene encoding the clearance receptor for atrial natriuretic peptide. Eur. J. Biochem. 237:1996;25-34
18. Yanaka N., Kotera J., Omori K. Isolation and characterization of the 5′-flanking regulatory region of the human natiuretic peptide receptor C gene. Endocrinology. 139:1998;1389-1400
19. Yasuda S., Kanna M., Sakuragi S., Kojima S., Nakayama Y., Miyazaki S., Matsuda T., Kangawa K., Nonogi H. Local delivery of single low-dose of C-type natriuretic peptide, an endogenous vascular modulator, inhibits neointimal hyperplasia in a balloon-injured rabbit iliac artery model. J. Cardiovasc. Pharmacol. 39:2002;784-788